Viva & practicalsDrNB Cardiology – Practicals

Transcatheter procedures in congenital heart disease: age and weight cut-offs

22 proceduresLast reviewed: October 2026
Merit MedScript seal

When is a child big enough for a device? Usual age and weight cut-offs for 22 transcatheter procedures in congenital heart disease, with the reason behind each — sheath size, vessel calibre, device fit and growth. Cut-offs are typical practice and vary with device, anatomy and centre.

How to present in the viva: Give the usual cut-off, then the reason (sheath size versus femoral vessel calibre, device size versus septum or vessel, and whether the implant can grow with the child), and finish with the exception — when it is done earlier as a rescue or palliative step.

AClosure of shunts, leaks and fistulae

1.Atrial septal defect (ASD) device closure

  • Cut-off: Usually age over 2–4 years or weight over about 15 kg (elective).
  • Rationale: To safely accommodate the large delivery sheaths (8 to 12 French) without causing femoral vein thrombosis or iliac venous injury. The atrial septum must also be large enough to hold the device without impinging on the SVC, IVC, mitral valve, or aortic root.
  • Exception: Can be performed in younger/smaller children (< 10 kg) if they have severe intractable right heart failure, though surgical closure is often preferred in very small infants.

2.Patent ductus arteriosus (PDA) device closure

  • Standard devices (e.g., Amplatzer Duct Occluder): Age > 6 months or Weight > 6 kg.
  • Premature infants: Weight > 700 gm  using specifically designed micro-devices (e.g., Amplatzer Piccolo Occluder).
  • Rationale: Delivery sheaths for standard devices (6 to 7 French) pose a risk of femoral vascular injury in small infants. The Piccolo device can be delivered through a 4 French microcatheter.

3.Ventricular septal defect (VSD) device closure

  • Perimembranous VSD: Weight > 8 to 10 kg (typically age > 1 to 2 years).
  • Muscular VSD: Weight > 5 kg.
  • Rationale: In smaller hearts, the rigid device discs can impinge on the aortic valve (causing aortic regurgitation) or the tricuspid valve. There is also a significantly higher risk of procedure-induced Complete Heart Block (CHB) in smaller infants due to the proximity of the conduction system.

4.Patent foramen ovale (PFO) device closure

  • Cut-off: Usually adults aged 18–60 years for PFO-associated stroke. In children (e.g., platypnoea–orthodeoxia or significant right-to-left shunting), weight over about 15 kg.
  • Rationale: The evidence base for PFO closure is predominantly in adults post-stroke. When indicated in children, the constraints are similar to ASD closure to accommodate 8 to 9 French delivery sheaths and ensure the device discs do not erode the adjacent structures.

5.Ruptured sinus of Valsalva (RSOV) device closure

  • Cut-off: Weight > 15 to 20 kg.
  • Rationale: RSOV is rare in early childhood and typically presents in older children or adults. Closure requires larger delivery sheaths and poses a high risk of device impingement on the coronary ostia or aortic valve leaflets in smaller aortic roots.

6.Coronary arteriovenous fistula (CAVF) closure

  • Cut-off (Coils): No strict minimum; can be performed in infants.
  • Cut-off (Vascular Plugs/Devices): Weight > 10 to 15 kg.
  • Rationale: Small fistulas in infants can be closed with micro-coils delivered through 4 French catheters. Large, high-flow fistulas require Amplatzer Vascular Plugs or similar devices, necessitating larger guide catheters (6 to 8 French) that are unsafe for neonatal arteries.

7.Aortopulmonary (AP) window device closure

  • Cut-off: Highly individualized, but typically restricted to Weight > 10 to 15 kg for transcatheter candidates.
  • Rationale: AP windows are almost exclusively treated surgically in neonates due to the massive shunt and early heart failure. Transcatheter closure is reserved for small, restrictive defects or residual postoperative defects, requiring a patient large enough to tolerate the delivery system without compromising the origins of the coronary arteries.

8.Fontan fenestration closure

  • Cut-off: Typically performed 6 to 12 months post-Fontan completion (Age > 3 to 5 years).
  • Rationale: The circulation must tolerate loss of the right-to-left "pop-off": test occlusion is done first, checking that Fontan pressure and cardiac output remain acceptable. Closure uses septal occluders or vascular plugs.

9.Baffle leak device closure

  • Cut-off: Weight > 15 kg.
  • Rationale: Post-Mustard/Senning patients often develop baffle leaks leading to right-to-left shunting and cyanosis. Closure utilizes ASD or PFO occluders. The patient must be large enough to safely navigate large delivery sheaths through complex, reconstructed venous pathways without tearing the baffle.

10.Paravalvular leak (PVL) closure

  • Cut-off: Typically Adult/GUCH (Weight > 30 kg).
  • Rationale: Congenital patients with multiple prior surgical valve replacements (especially mechanical valves) can develop severe haemolytic anaemia or heart failure from PVLs. This requires complex, often transseptal, navigation using 8 to 9 French steerable sheaths and specialized rectangular/square vascular plugs (e.g., Amplatzer Vascular Plug III), which cannot be safely manoeuvreed in paediatric hearts.

BValves, coarctation and vessel stenting

11.Coarctation of the aorta (CoA) interventions

  • Balloon angioplasty: No minimum age or weight. Can be performed in neonates, primarily for post-surgical recoarctation or as a bridge to definitive therapy in critically ill infants.
  • Stenting: Age > 8 to 10 years or Weight > 25 kg.
  • Rationale for stenting: A stented aortic segment will not grow with the child. Implantation is delayed until the child reaches a size where an adult-size stent can be safely delivered (requiring large sheaths) and subsequently post-dilated to adult dimensions (18 to 20 mm) as the child grows.

12.Transcatheter pulmonary valve implantation (TPVI)

  • Cut-off: Weight > 20 to 30 kg (typically > 7 to 10 years of age).
  • Rationale: Large valves (Melody, SAPIEN 3) need big delivery systems (Melody 22 F; SAPIEN 3 about 14–16 F), which risk iliofemoral injury in small children. The RVOT or conduit must also be large enough (usually ≥16 mm at implant).

13.Balloon pulmonary valvuloplasty (BPV) and aortic valvuloplasty (BAV)

  • Cut-off: No minimum age or weight.
  • Rationale: Routinely and safely performed in neonates (including premature infants) on day one of life for Critical Pulmonary Stenosis or Critical Aortic Stenosis.

14.Pulmonary artery (PA) branch stenting

  • Cut-off (Adult-Size Stents): Weight > 20 to 25 kg.
  • Cut-off (Pre-mounted / Low-Profile Stents): Can be done in smaller children (Weight > 10 kg), but requires future re-intervention or surgical unzipping.
  • Rationale: Similar to aortic coarctation stenting, deploying a stent in a small child "locks" the vessel size. To safely deliver large-diameter, large-cell stents that can be serially dilated to adult dimensions (up to 18-20 mm) as the child grows, the femoral veins must be large enough to accept 10 to 12 French sheaths.

15.Stenting of systemic veins (SVC/IVC)

  • Cut-off: Weight > 15 to 20 kg for definitive adult-sized stents.
  • Rationale: Seen in patients post-atrial switch (Mustard/Senning) or post-heart transplant presenting with baffle obstruction or caval stenosis. The femoral or jugular veins must be large enough to accommodate 10 to 12 French sheaths to deliver large-diameter (often 14 to 20 mm) stents.

CNeonatal and palliative procedures

16.Balloon atrial septostomy (Rashkind procedure)

  • Cut-off: No minimum age or weight (typically a neonatal procedure).
  • Rationale: A life-saving emergency procedure performed in the first hours or days of life for Transposition of the Great Arteries (TGA) to ensure adequate mixing of blood.

17.Atrial septal stenting or cutting-balloon septoplasty (beyond Rashkind)

  • Cut-off: No minimum age or weight.
  • Rationale: For neonates with hypoplastic left heart syndrome (HLHS) and a highly restrictive or intact atrial septum, standard Rashkind septostomy fails. These neonates require transcatheter cutting balloon septoplasty or direct atrial septal stenting on day one of life to decompress the left atrium and prevent fatal pulmonary venous hypertension.

18.Ductus arteriosus stenting (ductal-dependent lesions)

  • Cut-off: No minimum age or weight.
  • Rationale: This is a neonatal rescue or palliative procedure (an alternative to a surgical Blalock-Taussig shunt or continuous PGE1 infusion) for conditions like Pulmonary Atresia or severe Tetralogy of Fallot. It is performed in the first days of life, often in premature or low-birth-weight neonates.

19.Right ventricular outflow tract (RVOT) stenting

  • Cut-off: No minimum age or weight.
  • Rationale: Used as early palliation for symptomatic neonates with Tetralogy of Fallot (to avoid early neonatal complete repair or surgical shunts). Standard coronary stents are typically deployed via 4 to 5 French sheaths.

20.Major aortopulmonary collateral artery (MAPCA) coiling / vessel embolisation

  • Cut-off: No minimum age or weight.
  • Rationale: Can be performed in neonates utilizing 3 to 4 French microcatheters to deploy coils or vascular plugs in bleeding or excessive collateral vessels.

21.Venovenous collateral embolisation (post-Glenn/Fontan)

  • Cut-off: No minimum age or weight.
  • Rationale: Patients with a failing Fontan or Glenn often develop decompressing venovenous collaterals (e.g., SVC to pulmonary veins) leading to severe cyanosis. These can be coiled or plugged using low-profile 4 to 5 French diagnostic catheters at any age, provided the collateral is hemodynamically significant.

22.Transcatheter enlargement of a restrictive VSD

  • Standard Cutoff: No minimum age or weight (specialist centres only).
  • Rationale: Rarely, a restrictive VSD (or bulboventricular foramen) causing subaortic obstruction in single-ventricle or complex lesions is enlarged by stenting, perventricularly or by catheter; it is a salvage option when surgery is high risk.

Classes and cut-offs follow the ESC 2020–2024 and ACC/AHA guidelines current in October 2026; always apply your own institution's protocols.

meritmedscript.comDr. Sidhartha Mullapudi